Blood Stream Infection Testing - Global Market Outlook (2017-2026)
According to Stratistics MRC, the Global Blood Stream Infection Testing Market is expected to grow at a CAGR of 8.9% during the forecast period. Some of the factors such as rise in prevalence of infections such as abdominal infections, dental infections and increase in occurrence geriatric population are fueling the market growth. However, strict government rules associated to the safety and efficacy is limiting the market growth. Blood Stream Infection testing market provides ample opportunities to ongoing R&D activities in various countries across the globe.
Blood stream infection is a condition in which bacterial, fungal, or any infection is detected in the blood. It normally arises when infection in any part of body enters the blood stream and this infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult due to its regular symptoms such as chills, fever, diarrhea, vomiting. As a result, testing is mandatory for detection of infection in blood.
Amongst End User, Hospital Laboratories segment accounted held significant market share during the forecast period. The healthcare industry is steadily adopting automated solutions to diminish the cost incurred on staffing and to produce accurate results. Also, automated solutions aid healthcare professionals in reducing the time taken for manually intensive tasks. This allows researchers to focus extensively on patient consultation and precision in diagnosis and improving productivity. By geography, North America dominated the market during the forecast period due to the factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities in this region.
Some of the key players in Blood Stream Infection Testing market include Thermo Fisher Scientific Inc., Siemens Healthcare, F. Hoffmann-La Roche Ag., Danaher, Cepheid Inc, C. R. Bard, Inc., Biomérieux Inc., Becton, Dickinson And Company, Beckman Coulter Inc, Alere Inc. and Abbott Laboratories.
Test Types Covered:
Blood stream infection is a condition in which bacterial, fungal, or any infection is detected in the blood. It normally arises when infection in any part of body enters the blood stream and this infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult due to its regular symptoms such as chills, fever, diarrhea, vomiting. As a result, testing is mandatory for detection of infection in blood.
Amongst End User, Hospital Laboratories segment accounted held significant market share during the forecast period. The healthcare industry is steadily adopting automated solutions to diminish the cost incurred on staffing and to produce accurate results. Also, automated solutions aid healthcare professionals in reducing the time taken for manually intensive tasks. This allows researchers to focus extensively on patient consultation and precision in diagnosis and improving productivity. By geography, North America dominated the market during the forecast period due to the factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities in this region.
Some of the key players in Blood Stream Infection Testing market include Thermo Fisher Scientific Inc., Siemens Healthcare, F. Hoffmann-La Roche Ag., Danaher, Cepheid Inc, C. R. Bard, Inc., Biomérieux Inc., Becton, Dickinson And Company, Beckman Coulter Inc, Alere Inc. and Abbott Laboratories.
Test Types Covered:
- Conventional Blood Culture Tests
- Blood Gases
- Complete Blood Count (CBC)
- Culture of Skin Sore
- Cerebrospinal Fluid (CSF) Culture
- Platelet Count
- Urine Culture
- Chest X-Ray
- Clotting Studies
- Polymerase Chain Reaction (PCR) Method
- Nucleic Acid Testing
- Mass Spectroscopy
- Point-of-Care Testing
- Reagents
- Instruments
- Other Products
- Non-Conventional Testing
- Conventional Testing
- Mycobacteria
- Fungemia
- Bacteremia
- Hospital Laboratories
- Reference Laboratories
- Academic Research Laboratories
- Independent Diagnostic Centers
- Other End Users
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY TEST TYPE
5.1 Introduction
5.2 Conventional Blood Culture Tests
5.3 Blood Gases
5.4 Complete Blood Count (CBC)
5.5 Culture of Skin Sore
5.6 Cerebrospinal Fluid (CSF) Culture
5.7 Platelet Count
5.8 Urine Culture
5.9 Chest X-Ray
5.10 Clotting Studies
5.10.1 Fibrinogen Levels
5.10.2 Prothrombin Time (PT)
5.10.3 Partial Thromboplastin Time (PTT)
5.11 Polymerase Chain Reaction (PCR) Method
5.12 Nucleic Acid Testing
5.13 Mass Spectroscopy
5.14 Point-of-Care Testing
6 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY PRODUCT
6.1 Introduction
6.2 Reagents
6.3 Instruments
6.4 Other Products
7 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY TECHNOLOGY
7.1 Introduction
7.2 Non-Conventional Testing
7.3 Conventional Testing
8 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY APPLICATION
8.1 Introduction
8.2 Mycobacteria
8.3 Fungemia
8.4 Bacteremia
9 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY END USER
9.1 Introduction
9.2 Hospital Laboratories
9.3 Reference Laboratories
9.4 Academic Research Laboratories
9.5 Independent Diagnostic Centers
9.6 Other End Users
10 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY GEOGRAPHY
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 KEY DEVELOPMENTS
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 COMPANY PROFILING
12.1 Thermo Fisher Scientific Inc.
12.2 Siemens Healthcare
12.3 F. Hoffmann-La Roche Ag.
12.4 Danaher
12.5 Cepheid Inc
12.6 C. R. Bard, Inc.
12.7 Biomérieux Inc.
12.8 Becton, Dickinson And Company
12.9 Beckman Coulter Inc
12.10 Alere Inc.
12.11 Abbott Laboratories
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY TEST TYPE
5.1 Introduction
5.2 Conventional Blood Culture Tests
5.3 Blood Gases
5.4 Complete Blood Count (CBC)
5.5 Culture of Skin Sore
5.6 Cerebrospinal Fluid (CSF) Culture
5.7 Platelet Count
5.8 Urine Culture
5.9 Chest X-Ray
5.10 Clotting Studies
5.10.1 Fibrinogen Levels
5.10.2 Prothrombin Time (PT)
5.10.3 Partial Thromboplastin Time (PTT)
5.11 Polymerase Chain Reaction (PCR) Method
5.12 Nucleic Acid Testing
5.13 Mass Spectroscopy
5.14 Point-of-Care Testing
6 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY PRODUCT
6.1 Introduction
6.2 Reagents
6.3 Instruments
6.4 Other Products
7 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY TECHNOLOGY
7.1 Introduction
7.2 Non-Conventional Testing
7.3 Conventional Testing
8 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY APPLICATION
8.1 Introduction
8.2 Mycobacteria
8.3 Fungemia
8.4 Bacteremia
9 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY END USER
9.1 Introduction
9.2 Hospital Laboratories
9.3 Reference Laboratories
9.4 Academic Research Laboratories
9.5 Independent Diagnostic Centers
9.6 Other End Users
10 GLOBAL BLOOD STREAM INFECTION TESTING MARKET, BY GEOGRAPHY
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 KEY DEVELOPMENTS
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 COMPANY PROFILING
12.1 Thermo Fisher Scientific Inc.
12.2 Siemens Healthcare
12.3 F. Hoffmann-La Roche Ag.
12.4 Danaher
12.5 Cepheid Inc
12.6 C. R. Bard, Inc.
12.7 Biomérieux Inc.
12.8 Becton, Dickinson And Company
12.9 Beckman Coulter Inc
12.10 Alere Inc.
12.11 Abbott Laboratories
LIST OF TABLES
Table 1 Global Blood Stream Infection Testing Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Blood Stream Infection Testing Market Outlook, By Test Type (2016-2026) (US $MN)
Table 3 Global Blood Stream Infection Testing Market Outlook, By Conventional Blood Culture Tests (2016-2026) (US $MN)
Table 4 Global Blood Stream Infection Testing Market Outlook, By Blood Gases (2016-2026) (US $MN)
Table 5 Global Blood Stream Infection Testing Market Outlook, By Complete Blood Count (CBC) (2016-2026) (US $MN)
Table 6 Global Blood Stream Infection Testing Market Outlook, By Culture of Skin Sore (2016-2026) (US $MN)
Table 7 Global Blood Stream Infection Testing Market Outlook, By Cerebrospinal Fluid (CSF) Culture (2016-2026) (US $MN)
Table 8 Global Blood Stream Infection Testing Market Outlook, By Platelet Count (2016-2026) (US $MN)
Table 9 Global Blood Stream Infection Testing Market Outlook, By Urine Culture (2016-2026) (US $MN)
Table 10 Global Blood Stream Infection Testing Market Outlook, By Chest X-Ray (2016-2026) (US $MN)
Table 11 Global Blood Stream Infection Testing Market Outlook, By Clotting Studies (2016-2026) (US $MN)
Table 12 Global Blood Stream Infection Testing Market Outlook, By Fibrinogen Levels (2016-2026) (US $MN)
Table 13 Global Blood Stream Infection Testing Market Outlook, By Prothrombin Time (PT) (2016-2026) (US $MN)
Table 14 Global Blood Stream Infection Testing Market Outlook, By Partial Thromboplastin Time (PTT) (2016-2026) (US $MN)
Table 15 Global Blood Stream Infection Testing Market Outlook, By Polymerase Chain Reaction (PCR) Method (2016-2026) (US $MN)
Table 16 Global Blood Stream Infection Testing Market Outlook, By Nucleic Acid Testing (2016-2026) (US $MN)
Table 17 Global Blood Stream Infection Testing Market Outlook, By Mass Spectroscopy (2016-2026) (US $MN)
Table 18 Global Blood Stream Infection Testing Market Outlook, By Point-of-Care Testing (2016-2026) (US $MN)
Table 19 Global Blood Stream Infection Testing Market Outlook, By Product (2016-2026) (US $MN)
Table 20 Global Blood Stream Infection Testing Market Outlook, By Reagents (2016-2026) (US $MN)
Table 21 Global Blood Stream Infection Testing Market Outlook, By Instruments (2016-2026) (US $MN)
Table 22 Global Blood Stream Infection Testing Market Outlook, By Other Products (2016-2026) (US $MN)
Table 23 Global Blood Stream Infection Testing Market Outlook, By Technology (2016-2026) (US $MN)
Table 24 Global Blood Stream Infection Testing Market Outlook, By Non-Conventional Testing (2016-2026) (US $MN)
Table 25 Global Blood Stream Infection Testing Market Outlook, By Conventional Testing (2016-2026) (US $MN)
Table 26 Global Blood Stream Infection Testing Market Outlook, By Application (2016-2026) (US $MN)
Table 27 Global Blood Stream Infection Testing Market Outlook, By Mycobacteria (2016-2026) (US $MN)
Table 28 Global Blood Stream Infection Testing Market Outlook, By Fungemia (2016-2026) (US $MN)
Table 29 Global Blood Stream Infection Testing Market Outlook, By Bacteremia (2016-2026) (US $MN)
Table 30 Global Blood Stream Infection Testing Market Outlook, By End User (2016-2026) (US $MN)
Table 31 Global Blood Stream Infection Testing Market Outlook, By Hospital Laboratories (2016-2026) (US $MN)
Table 32 Global Blood Stream Infection Testing Market Outlook, By Reference Laboratories (2016-2026) (US $MN)
Table 33 Global Blood Stream Infection Testing Market Outlook, By Academic Research Laboratories (2016-2026) (US $MN)
Table 34 Global Blood Stream Infection Testing Market Outlook, By Independent Diagnostic Centers (2016-2026) (US $MN)
Table 35 Global Blood Stream Infection Testing Market Outlook, By Other End Users (2016-2026) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America, and Middle East & Africa are represented in the same manner above.
Table 1 Global Blood Stream Infection Testing Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Blood Stream Infection Testing Market Outlook, By Test Type (2016-2026) (US $MN)
Table 3 Global Blood Stream Infection Testing Market Outlook, By Conventional Blood Culture Tests (2016-2026) (US $MN)
Table 4 Global Blood Stream Infection Testing Market Outlook, By Blood Gases (2016-2026) (US $MN)
Table 5 Global Blood Stream Infection Testing Market Outlook, By Complete Blood Count (CBC) (2016-2026) (US $MN)
Table 6 Global Blood Stream Infection Testing Market Outlook, By Culture of Skin Sore (2016-2026) (US $MN)
Table 7 Global Blood Stream Infection Testing Market Outlook, By Cerebrospinal Fluid (CSF) Culture (2016-2026) (US $MN)
Table 8 Global Blood Stream Infection Testing Market Outlook, By Platelet Count (2016-2026) (US $MN)
Table 9 Global Blood Stream Infection Testing Market Outlook, By Urine Culture (2016-2026) (US $MN)
Table 10 Global Blood Stream Infection Testing Market Outlook, By Chest X-Ray (2016-2026) (US $MN)
Table 11 Global Blood Stream Infection Testing Market Outlook, By Clotting Studies (2016-2026) (US $MN)
Table 12 Global Blood Stream Infection Testing Market Outlook, By Fibrinogen Levels (2016-2026) (US $MN)
Table 13 Global Blood Stream Infection Testing Market Outlook, By Prothrombin Time (PT) (2016-2026) (US $MN)
Table 14 Global Blood Stream Infection Testing Market Outlook, By Partial Thromboplastin Time (PTT) (2016-2026) (US $MN)
Table 15 Global Blood Stream Infection Testing Market Outlook, By Polymerase Chain Reaction (PCR) Method (2016-2026) (US $MN)
Table 16 Global Blood Stream Infection Testing Market Outlook, By Nucleic Acid Testing (2016-2026) (US $MN)
Table 17 Global Blood Stream Infection Testing Market Outlook, By Mass Spectroscopy (2016-2026) (US $MN)
Table 18 Global Blood Stream Infection Testing Market Outlook, By Point-of-Care Testing (2016-2026) (US $MN)
Table 19 Global Blood Stream Infection Testing Market Outlook, By Product (2016-2026) (US $MN)
Table 20 Global Blood Stream Infection Testing Market Outlook, By Reagents (2016-2026) (US $MN)
Table 21 Global Blood Stream Infection Testing Market Outlook, By Instruments (2016-2026) (US $MN)
Table 22 Global Blood Stream Infection Testing Market Outlook, By Other Products (2016-2026) (US $MN)
Table 23 Global Blood Stream Infection Testing Market Outlook, By Technology (2016-2026) (US $MN)
Table 24 Global Blood Stream Infection Testing Market Outlook, By Non-Conventional Testing (2016-2026) (US $MN)
Table 25 Global Blood Stream Infection Testing Market Outlook, By Conventional Testing (2016-2026) (US $MN)
Table 26 Global Blood Stream Infection Testing Market Outlook, By Application (2016-2026) (US $MN)
Table 27 Global Blood Stream Infection Testing Market Outlook, By Mycobacteria (2016-2026) (US $MN)
Table 28 Global Blood Stream Infection Testing Market Outlook, By Fungemia (2016-2026) (US $MN)
Table 29 Global Blood Stream Infection Testing Market Outlook, By Bacteremia (2016-2026) (US $MN)
Table 30 Global Blood Stream Infection Testing Market Outlook, By End User (2016-2026) (US $MN)
Table 31 Global Blood Stream Infection Testing Market Outlook, By Hospital Laboratories (2016-2026) (US $MN)
Table 32 Global Blood Stream Infection Testing Market Outlook, By Reference Laboratories (2016-2026) (US $MN)
Table 33 Global Blood Stream Infection Testing Market Outlook, By Academic Research Laboratories (2016-2026) (US $MN)
Table 34 Global Blood Stream Infection Testing Market Outlook, By Independent Diagnostic Centers (2016-2026) (US $MN)
Table 35 Global Blood Stream Infection Testing Market Outlook, By Other End Users (2016-2026) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America, and Middle East & Africa are represented in the same manner above.
